Italia markets close in 7 hours 43 minutes

ABIO Sep 2024 5.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,40000,0000 (0,00%)
Alla chiusura: 12:13PM EDT
Schermo intero
Chiusura precedente2,4000
Aperto2,4000
Denaro1,6500
Domanda2,9000
Prezzo d'esercizio5,00
Scadenza2024-09-20
Min-Max giorno2,4000 - 2,4000
Contratto - Min-MaxN/D
Volume10
Open Interest10
  • GlobeNewswire

    ARCA biopharma Announces Second Quarter 2023 Financial Results

    Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., July 21, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported second quarter 2023 financial results and provided a corporate update. In April 2022, the Board of Di